TINA KLEIN: Open Payments
NPI 1699438390 · NORTH PORT, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$759 in 29 payments from 12 companies in 2025. Trend: 2023 $1,192 · 2024 $3,430 · 2025 $759
Food & beverage: $680Education: $79
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $152 |
| Astellas Pharma US Inc | 4 | $150 |
| Sumitomo Pharma America, Inc. | 6 | $145 |
| Phathom Pharmaceuticals, Inc. | 1 | $80 |
| Lilly USA, LLC | 2 | $44 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Dexcom, Inc. | 1 | $32 |
| Exact Sciences Corporation | 1 | $29 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Abbott Laboratories | 1 | $23 |
Products named: GEMTESA, Ozempic, VOQUEZNA, Veozah, MOUNJARO, REXULTI, Rybelsus, Dexcom G6 Transmitter.
Industry payments across FL — which companies pay providers there.
